Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 7, 2016; 22(1): 145-154
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.145
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.145
Table 1 Cross-resistance data for the most frequent resistant hepatitis B virus variant
HBV variants | Level of susceptibility | ||||
Lamivudine | Telbivudine | Entecavir | Adefovir | Tenofovir | |
Wild-tipe | S | S | S | S | S |
M204V | R | S | I | I | S |
M204I | R | R | I | I | S |
L180M + M204V | R | R | I | I | S |
A181A/T | I | S | S | R | S |
N236T | S | S | S | R | I |
L180M + M204V/I ± I196T ± V173L ± M250V | R | R | R | S | S |
L180M + M204V/I ± T184G ± S202I/G | R | R | R | S | S |
- Citation: Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 2016; 22(1): 145-154
- URL: https://www.wjgnet.com/1007-9327/full/v22/i1/145.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i1.145